PAPER Werner P, Karnieli-Miller O, Eidelman S
SEARCH RESULTS
330059 RESULTS
PAPER Farkas M, Keskitalo S, Smith DE, Bain N, Semmler A, Ineichen B, Smulders Y, Blom H, Kulic L, Linnebank M
Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg?
J Alzheimers Dis. 2013 Jan 1;33(4):1097-104. PubMed: 23099812PAPER Peters OM, Connor-Robson N, Sokolov VB, Aksinenko AY, Kukharsky MS, Bachurin SO, Ninkina N, Buchman VL
Chronic Administration of Dimebon Ameliorates Pathology in TauP301S Transgenic Mice.
J Alzheimers Dis. 2013 Jan 1;33(4):1041-9. PubMed: 23099813PAPER Hanford N, Figueiro M
Light therapy and Alzheimer's disease and related dementia: past, present, and future.
J Alzheimers Dis. 2013 Jan 1;33(4):913-22. PubMed: 23099814PAPER Lu J, E L, Roy N, Hutfles L, Selfridge E, Funk E, Burns JM, Swerdlow RH
Effect of cholinergic signaling on neuronal cell bioenergetics.
J Alzheimers Dis. 2013 Jan 1;33(4):1135-46. PubMed: 23099815PAPER Herculano B, Tamura M, Ohba A, Shimatani M, Kutsuna N, Hisatsune T
β-Alanyl-L-Histidine Rescues Cognitive Deficits Caused by Feeding a High Fat Diet in a Transgenic Mouse Model of Alzheimer's Disease.
J Alzheimers Dis. 2013 Jan 1;33(4):983-97. PubMed: 23099816PAPER Gong CX, Alonso Ad, Wang JZ
A life dedicated to Alzheimer's disease research: in memory of Inge Grundke-Iqbal (1937-2012).
Acta Neuropathol. 2012 Dec;124(6):907-8. PubMed: 23099890PAPER Harada R, Okamura N, Furumoto S, Tago T, Maruyama M, Higuchi M, Yoshikawa T, Arai H, Iwata R, Kudo Y, Yanai K
Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):125-32. PubMed: 23100049PAPER Kempf SJ, Azimzadeh O, Atkinson MJ, Tapio S
Long-term effects of ionising radiation on the brain: cause for concern?
Radiat Environ Biophys. 2012 Oct 26; PubMed: 23100112PAPER Cameron B, Tse W, Lamb R, Li X, Lamb BT, Landreth GE
Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.
J Neurosci. 2012 Oct 24;32(43):15112-23. PubMed: 23100432PAPER Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, Mitani A, Joyner D, Thyssen DH, Bacskai BJ, Frosch MP, Spires-Jones TL, Finn MB, Holtzman DM, Hyman BT
Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
J Neurosci. 2012 Oct 24;32(43):15181-92. PubMed: 23100439PAPER Costanza A, Bouras C, Kövari E, Giannakopoulos P
[Alzheimer disease: from pathogenetic issues to clinical perspectives].
Rev Med Suisse. 2012 Sep 19;8(354):1770-2, 1774. PubMed: 23097914PAPER Lazarczyk MJ, Hof PR, Bouras C, Giannakopoulos P
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals.
BMC Med. 2012;10:127. PubMed: 23098093PAPER Shao H, Breitner JC, Whitmer RA, Wang J, Hayden K, Wengreen H, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K, Zandi PP,
Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.
Neurology. 2012 Oct 30;79(18):1846-52. PubMed: 23100399PAPER Henderson VW, Rocca WA
Estrogens and Alzheimer disease risk: is there a window of opportunity?
Neurology. 2012 Oct 30;79(18):1840-1. PubMed: 23100400Current Filters
No filters selected